The Journal of Rheumatology
S

HCQ in Patients With Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials

By The Journal of Rheumatology FEATURING Stephen J. Balevic
By The Journal of Rheumatology FEATURING Stephen J. Balevic
96 views
February 18, 2021
Comments 0
Login to view comments. Click here to Login

Related Videos

15:26

The Facts About COVID-19 Delta Breakthrough Infection and Vaccine Bo…

Cleveland Clinic Rheumatology and Immunology Series

L. Calabrese

6.4K views
01:58

The COVID-19 Global Rheumatology Alliance: Collecting Evidence-Based…

Covid-19 Global Rheumatology Alliance

P. Robinson, J. Yazdany

69 views
18:24

Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

70 views
29:14

Cytokine Storm: Where Rheumatologists, Oncologists, and ID Meet

Cleveland Clinic Rheumatology

D. Fajgenbaum

188 views
14:51

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

ACR Convergence 2021 Coverage

S. Sattui Cortes

153 views
15:27

Treatment of RMD COVID-19 Patients: Are Anti-Rheumatic Drugs Proving…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

L. Wise

372 views
07:43

Cleveland Clinic ACR 2020 Updates on COVID-19: Has Tocilizumab Prove…

Cleveland Clinic Rheumatology and Immunology Series

L. Calabrese

1.0K views
18:35

COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

L. Wise

670 views
29:06

Vaccines for IMIDS: State of the Art

Cleveland Clinic Rheumatology

C. Calabrese

299 views
51:16

COVID-19 and Rheumatic Diseases

Yale School of Medicine

V. Chowdhary

143 views
24:32

Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of Labs …

RheumNow

J. Cush, R. Tate, Y. Yusof, B. Mehta, O. Petryna

196 views
19:39

Principles of Managing COVID-19 in High Risk Outpatients

Cleveland Clinic Rheumatology

C. Calabrese

134 views
22:24

JAK Inhibitors in the COVID-19 Era: Assessing the Risks and Benefit

Cleveland Clinic Rheumatology

K. Winthrop

100 views
05:35

Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection…

The Journal of Rheumatology

J. Curtis

85 views
22:39

The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment

The Journal of Rheumatology

E. Silverman, J. Rosenbaum, J. Reveille, K. Winthrop

64 views
20:38

COVID-19 and the Risks From Immunomodulatory Therapies

Cleveland Clinic Rheumatology

Z. Wallace

61 views
10:00

RheumNow Updates on Pemphigus Vulgaris, the Efficacy of JAK Inhibito…

RheumNow

J. Cush

60 views
05:29

Rheumatic Disease Patients with COVID-19: Is Timing Important for Bi…

RheumNow

J. Cush

54 views
26:25

Hyperinflammation and Immunomodulatory Drugs Trials in COVID-19

Cleveland Clinic Rheumatology

P. Mehta

48 views
14:08

Managing COVID-19 in Immune-Mediated Inflammatory Disease Patients: …

Cleveland Clinic Rheumatology

C. Calabrese, L. Calabrese, P. Mehta

35 views
AUTOPLAY